Radiopharmaceuticals continue to see increasing levels of activity by nearly every measure. In 2019 there were as many deals, agreements, and approvals as in the previous 3 years combined, and we at The Bracken Group predicted that the growth would only pick up steam in 2020. That is, in fact, what happened: The industry topped the 2019 high water mark by 50%.
What will 2021 bring? Stay tuned. The Bracken Group continues to work in and monitor this developing field.
We invite you to share this image with colleagues, use it in PowerPoint slides, or post it on LinkedIn.